Summary:
Acute graft-versus-host disease (aGVHD) is one of the major problems following allogeneic peripheral blood stem cell transplantation (allo-PBSCT). In order to investigate the pathogenesis of human aGVHD, we analyzed cytokine gene expression and cytokine secretion by peripheral blood mononuclear cells (PBMC) in 30 patients who underwent allo-PBSCT. In this study, reverse transcription-polymerase chain reaction (RT-PCR) was used to explore the mRNA expression of interleukin (IL)-2, interferon (IFN)-γ, IL-4, IL-10 and IL-12 in the PBMC of allo-PBSCT patients with aGVHD and in controls. The concentrations of these cytokines and of IL-18 were also measured by means of ELISA in medium obtained from cultured leukocytes after stimulation with PHA or LPS. Compared with the normal allo-PBSCT group (n=14), IL-2 and IFN-γ were detected more frequently in aGVHD group (n=16). IL-12 and IL-18 were elevated, while IL-10 level decreased in the same group. There is no difference in IL-4 gene expression between patients with or without aGVHD, but the concentration of IL-4 for patients with grade II–IV aGVHD decreased. These data suggest that IL-2, IFN-γ, IL-12 and IL-18 play important roles in the development of aGVHD in humans.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Blazar BR, Korngold R, Vallera DA et al. Recent advances in graft-versus-host disease prevention. Immunol Res 1997; 157: 79–109.
Ferrara JLM, Deeg HJ . Graft-versus-host disease. N Engl J Med 1991; 324: 667–674.
Jadus MR, Wepsic HT . The role of cytokines in graft-versus-host reaction and disease. Bone Marrow Transplant 1992; 10: 1–14.
Ferrara JLM . The cytokine modulation of acute graft-versus-host disease. Bone Marrow Transplant 1998; 21 (Suppl. 3): S13–S15.
Mosmann TR, Chrwinski H, Bond MW et al. Two types of murine helper T cell clone: 1. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348–2357.
Seder RA . The functional role of CD8+ T helper type 2 cells. J Exp Med 1995; 181: 5.
Krenger W, Ferrara JLM . Graft-versus-host disease disease and the Th1/Th2 paradigm. Immunol Res 1996; 15: 50–73.
Strom TB, Roy-Chaudhury P, Manfro R et al. The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol 1996; 8: 688–693.
Yang YG, Sergio JJ, Pearson DA et al. Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice. Blood 1997; 90: 4651–4660.
Tanaka J, Imamura M, Kasai M et al. Cytokine gene expression in the mixed lymphocyte culture in allogeneic bone marrow transplants as a predictive method for transplantation-related complications. Br J Haematol 1994; 87: 415–418.
Tanaka J, Imamura M, Kasai M et al. Cytokine gene expression by concanavalin A-stimulated peripheral mononuclear cells after bone marrow transplantation: an indicator of immunological abnormality due to chronic graft-versus-host disease. Bone Marrow Transplant 1994; 14: 695–701.
Carayol G, Bourhis JH, Guillard M et al. Quantitative analysis of T helper 1, T helper 2, and inflammatory cytokine expression in patients after allogeneic bone marrow transplantation. Transplantation 1997; 63: 1307–1313.
Piotr G, Nicoletta H . Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal Biochem 1987; 162: 156–159.
Socie G, Loiseau P, Tamouza R . Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation 2001; 72: 699–706.
Nawa Y, Teshima T, Sunami K et al. G-CSF reduces IFN-gamma and IL-4 production by T cells after allogeneic stimulation by indirectly modulating monocyte function. Bone Marrow Transplant 2000; 25: 1035–1040.
Ju XP, Wang JM, Zhang WP et al. A study on the relations of soluble interleukin-2 receptor and CD25+ cell with acute graft-versus-host disease. Chinese J Intern Med 2001; 40: 222–225.
Roy J, Blazar BR, Ochs L et al. The tissue expression of cytokines in human acute cutaneous graft-versus-host disease. Transplantation 1995; 60: 343–348.
Krenger W, Hill GR, Ferrara JLM . Cytokine cascades in acute graft-versus-host disease. Transplantation 1997; 64: 553–558.
Yabe M, Yabe H, Hattori K et al. Role of interleukin-12 in the development of acute graft-versus-host disease in bone marrow transplant patients. Bone Marrow Transplant 1999; 24: 29–34.
Roy J, Platt JL, Weisdorg DJ . The immunopathology of upper gastrointestinal acute graft-versus-host disease: lymphoid cells and endothelial adhesion molecules. Transplantation 1993; 55: 572–578.
Hsu DH, de Waal Malefyt R, Fiorentino DF et al. Expression of interleukin-10 activity by Epstein–Barr protein BCRFI. Science 1990; 250: 830–832.
Vieira P, de Waal Malefyt R, Dang MN et al. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clone:homology to Epstein–Barr virus open reading frame BCRFI. Proc Natl Acad Sci USA 1991; 88: 1172–1176.
Fiorentino DF, Zlotnik A, Vieira P et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146: 3444–3451.
de Waal Malefyt R, Haanen J, Spits H et al. Interleukin 10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991; 174: 915–924.
Baker KS, Roncarolo M-G, Peter C et al. High spontaneous IL-10 production in unrelated bone marrow transplantation recipients is associated with fewer transplant-related complications and early death. Bone Marrow Transplant 1999; 23: 1123–1129.
Takatsuka H, Takemoto Y, Okamoto et al. Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation. Bone Marrow Transplant 1999; 24: 1005–1007.
Lin MT, Storer B, Martin PJ et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med 2003; 349: 2201–2210.
Fiorentino DF, Zlotnik A, Mosmann TR et al. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815–3822.
Holler E, Kay R, Sillibourne J et al. Prognostic significance of increased IL10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplant 2000; 25: 237–241.
Nakamura H, Komatsu K, Ayaki M et al. Serum levels of soluble IL-2 receptor, IL-18, and IFN-gamma in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation. J Allergy Clin Immunol 2000; 106: S45–50.
Fujimori Y, Takatsuka H, Takemoto Y et al. Elevated interleukin-18 levels during acute graft-versus-host disease after allogeneic bone marrow transplantation. Br J Haematol 2000; 109: 652–657.
Itoi H, Fujimori Y, Tsutsui et al. Fas ligand-induced caspase-1-dependent accumulation of interleukin-18 in mice with acute graft-versus-host disease. Blood 2001; 98: 235–237.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ju, X., Xu, B., Xiao, Z. et al. Cytokine expression during acute graft-versus-host disease after allogeneic peripheral stem cell transplantation. Bone Marrow Transplant 35, 1179–1186 (2005). https://doi.org/10.1038/sj.bmt.1704972
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704972
Keywords
This article is cited by
-
CXCL10 can be detected non-invasively from the skin of children with acute skin GvHD
Bone Marrow Transplantation (2016)